TCTMD9d
PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE
The trial adds much-needed randomized data to an area where it’s been lacking. Questions about methods muddy interpretation.
Healthline3d
Medications for Pulmonary Embolism
The exact treatment for PE depends on its severity and whether you need critical treatment in an emergency room setting. PE medications are usually considered before medical procedures.
PE Hub10d
King & Spalding’s Rick Zall: Behavioral health, home-based care, digital therapeutics ripe for PE
KKR's acquisition of SunFireMatrix and Consello's purchase of EHE Health are among the deals that exemplify the new trends.
Endovascular Today5d
Endovascular Engineering’s Helo PE Thrombectomy System Evaluated in Pilot ENGULF Trial
Julie Bulman, MD, presented the results of the pilot ENGULF trial. The two-phase, prospective, single-arm study assessed the ...
MassDevice9d
Inari Medical’s FlowTriever meets primary endpoint in pulmonary embolism trial
(Nasdaq:NARI) today announced positive results from its prospective PEERLESS trial for the FlowTriever system.
MassDevice13d
Jupiter Endovascular reports first patient treated in U.S. study of Vertex pulmonary embolectomy system
Jupiter Endovascular today announced the first U.S. patient treated in its SPIRARE II U.S. pivotal study for the Vertex ...
Large-bore mechanical thrombectomy yields better outcomes for intermediate-risk pulmonary embolism
Findings from the first international randomized controlled trial to compare patient outcomes following treatment with ...
Endovascular Today4d
Resource Utilization and Outcomes With Penumbra’s CAVT in Intermediate-Risk PE Patients Compared to Other Treatment Modalities
A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with ...
Business Insider9d
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
“These results are crucial to guiding optimal PE treatment decisions, providing strong evidence that FlowTriever may reduce clinical deterioration and the need for reintervention through more ...